FDA
-
-
-
-
-
-
-
AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa
-
-
-
-
-
-
-
Biogen (BIIB) to Acquire Remedy Pharmaceuticals' Phase 3 Candidate CIRARA for Large Hemispheric Stroke
-
-
-
-
-
-
-
Biogen Highlights Advances from Its Neurology Research Programs and Portfolio of Innovative Medicines at AAN Congress
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

